ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,966, issued on July 15, was assigned to Poseida Therapeutics Inc. (San Diego).
"Inducible caspases and methods for use" was invented by Eric M. Ostertag (San Diego) and Devon Shedlock (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides inducible caspase polypeptides, compositions comprising inducible caspase polypeptides and sequences encoding the same, cells modified to express the polypeptides and compositions of the disclosure, as well as methods of making and methods of using same for adoptive cell therapy."
The patent was filed on June 13, 2023, under Application No. 18/333,904.
*For further information, includin...